Cited by 95Retinoids in leukemia and cellular processesProtein Kinase Regulation and GTPase SignalingPeroxisome Proliferator-Activated Receptors

A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK

Piskunov, A, Rochette-Egly, C·2012·Oncogene

Abstract

Retinoic acid (RA) regulates several gene programs by nuclear RA receptors (RARs) that are ligand-dependent transcriptional transregulators. The basic mechanism for switching on transcription of cognate-target genes involves RAR binding at specific response elements and a network of interactions with coregulatory protein complexes. In addition to these classical genomic effects, we recently demonstrated that RA also induces the rapid activation of the p38MAPK/MSK1 pathway, with characteristic downstream consequences on the phosphorylation of RARs and the expression of their target genes. Here, we aimed at deciphering the underlying mechanism of the rapid non-genomic effects of RA. We highlighted a novel paradigm in which a fraction of the cellular RARα pool is present in membrane lipid rafts, where it forms complexes with G protein alpha Q (Gαq) in response to RA. This rapid RA-induced formation of RARα/Gαq complexes in lipid rafts is required for the activation of p38MAPK that occurs in response to RA. Accordingly, in RA-resistant cancer cells, characterized by the absence of p38MAPK activation, RARα present in membrane lipid rafts does not associate with Gαq, pointing out the essential contribution of RARα/Gαq complexes in RA signaling.

Integrity signals

Registry

Crossref · 10.1038/onc.2011.499

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In cells that respond to RA via the activation of p38MAPK, RARα is present in lipid rafts where it forms complexes with Gαq proteins.

    “Indeed, in cells that respond to RA via the activation of p38MAPK, RAR ␣ is present in lipid rafts where it forms complexes with G ␣ q proteins ( 115 ) ( Fig. 5A ).”
  • RA activates p38MAPK in fibroblasts, mouse embryo carcinoma cells, mammary breast tumor cells, and leukemia cells.

    “RA activates the p38 mitogen-activated protein kinase (p38MAPK) in fi broblasts, mouse embryo carcinoma cells, mammary breast tumor cells, and leukemia cells ( 96,111,114,115 ).”
  • RA-induced activation of the two MAPK pathways is subsequent to activation of upstream cascades involving Rho-GTPases, PI3K and/or PKB/Akt.

    “Nevertheless, the RA-induced activation of the two MAPK pathways is subsequent to the activation of upstream cascades involving Rho-GTPases ( 114, 115, 117 ), phosphoinositide 3-kinase (PI3K) and/or protein kinase B (PKB)/Akt ( 120, 121, 123 ), suggesting an atypical, nongenomic activation event similar to that described for steroid nuclear receptors ( 124, 125 ).”
  • In these cancers and others, the RA-induced activation of the MAPK pathway is abrogated, and RARα and RXRα are aberrantly phosphorylated.

    “Most interestingly, in these cancers and others, the RA-induced activation of the MAPK pathway is abrogated ( 115 ), and RAR ␣ and RXR ␣ are aberrantly phosphorylated ( 166-168 ).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Piskunov, A., & Rochette-Egly, C.
Affiliations
Centre National de la Recherche Scientifique (FR)
Venue
Oncogene
Published
2011-11-07
Volume
31
Issue
28
Pages
3333-3345
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2055007053
Cited by
95
References
9
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 10 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 9 · 2014: 12 · 2013: 13 · 2012: 1
FWCI
3.51
Type
journal article
Language
en
Open access
closed
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Agence Nationale de la Recherche (ANR-09-BLAN-0297, ANR-05-BLAN-0390)
  • Institut National Du Cancer
  • Institute of Cancer Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
retinoic acid receptor alpha, RARα, lipid rafts, p38 MAPK activation, MSK1, retinoic acid resistance, cancer cells
MeSH terms
Retinoic Acid Receptor alpha, Enzyme Activation, Humans, Protein Binding, Tretinoin, Signal Transduction, Receptors, Retinoic Acid, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Protein Transport, Membrane Microdomains, GTP-Binding Protein alpha Subunits, Gq-G11, Cell Line, Tumor, p38 Mitogen-Activated Protein Kinases, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review